Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00570_DB00701_nanopub.RAEH2xFI2T8ca5q42O1JogCMxLJ4-fXjlHFd91q8SoYn0#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00570_DB00701 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00570_DB00701 label "DDI between Vinblastine and Amprenavir - Amprenavir, a strong CYP3A4 inhibitor, may decrease the metabolism of Vinblastine. Consider alternate therapy to avoid Vinblastine toxicity. Monitor for changes in the therapeutic/adverse effects of Vinblastine if Amprenavir is initiated, discontinued or dose changed. [drugbank_resource:DB00570_DB00701]" assertion.
- drugbank_resource:DB00570_DB00701 identifier "drugbank_resource:DB00570_DB00701" assertion.
- drugbank_resource:DB00570_DB00701 title "DDI between Vinblastine and Amprenavir - Amprenavir, a strong CYP3A4 inhibitor, may decrease the metabolism of Vinblastine. Consider alternate therapy to avoid Vinblastine toxicity. Monitor for changes in the therapeutic/adverse effects of Vinblastine if Amprenavir is initiated, discontinued or dose changed." assertion.
- drugbank:DB00570 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00570_DB00701 assertion.
- drugbank:DB00701 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00570_DB00701 assertion.